Europe sells linagliptin as Trajenta. Here is what 30 days of the 5 mg tablet cost in seven places, from official price lists.
Researched with AI assistance; every figure is checked against the primary source cited on this page before publishing. How we work →
Tradjenta 5 mg (linagliptin; sold in Europe as Trajenta) is one tablet once a day for type 2 diabetes (FDA label) — so 30 days = 30 tablets. Swiss and Austrian packs hold 30 tablets; UK and Dutch packs hold 28, which we scale to 30 (our calculation: pack price ÷ 28 × 30). US dollars at European Central Bank reference rates of November 6, 2026. The price types differ — list price, negotiated price, pharmacy acquisition cost, retail price — and are labelled.
TRADJENTA / TRAJENTA (LINAGLIPTIN) 5 MG · 30 DAYS = 30 TABLETS
Price by country, November 2026
Packs of 28 scaled to 30 tablets (our calculation). No official price in Germany or France.
| Country | Official price | 30 days in US dollars | What a patient typically pays |
|---|---|---|---|
| 🇺🇸 United States (pharmacy cost) | $16.79540 per 5 mg tablet (CMS NADAC, Nov 4, 2026) | $504 | — |
| 🇺🇸 United States (list, 2024) | $488 for a 30-day supply (CMS, 2024) | $488 | — |
| 🇺🇸 United States (Medicare, 2027) | $78 negotiated price per 30-day supply, from Jan 1, 2027 (CMS); $2.794808 per tablet | $84 | Depends on the Part D plan and coverage phase |
| 🇬🇧 United Kingdom | Linagliptin 5 mg £33.26 for 28 tablets (NHS Drug Tariff price, since Dec 1, 2011) | $48 | £9.90 per item in England; free in Scotland, Wales and Northern Ireland |
| 🇨🇭 Switzerland | Trajenta CHF 56.45 for 30 tablets (public price; reimbursed with limitations) | $69 | 10% share after the annual deductible |
| 🇦🇹 Austria | Trajenta €47.45 for 30 tablets (social-insurance price excl. VAT; effective price may be lower under a price model) | $53 | €7.55 prescription fee per pack; for specified uses, with documentation |
| 🇳🇱 Netherlands | Trajenta €32.67 for 28 tablets (average pharmacy price) | $39 | Fully reimbursed under conditions; counts toward the annual deductible |
| 🇫🇷 France | No linagliptin product in the public medicines database | — | — |
| 🇩🇪 Germany | No statutory price ceiling (Festbetrag) for linagliptin; no official price found | — | — |
We compare prices; we do not recommend where to buy medicine. Whether to start, stop or switch a diabetes medicine is a decision for your doctor.
The $78 is the price Medicare negotiated under the Inflation Reduction Act for a 30-day supply, effective January 1, 2027. CMS’s data file sets $2.794808 per tablet, or $84 for 30 tablets (our calculation). In 2024 about 274,000 people with Medicare Part D used Tradjenta, and Part D spent $1.13 billion on it before rebates (CMS).
The Netherlands, the UK, Austria and Switzerland publish an official price for linagliptin 5 mg — about $39 to $69 for 30 tablets at ECB rates, or 8% to 14% of what US pharmacies pay (our calculation: $39 ÷ $504 and $69 ÷ $504). Even Medicare’s 2027 price, $84 for 30 tablets, is above all four.
Since June 17, 2026 the NHS lists Boehringer Ingelheim’s product as “Linagliptin 5mg tablets” instead of Trajenta, at the same £33.26 for 28 tablets; the Trajenta pack is marked discontinued (dm+d). In Germany the Joint Federal Committee found that an added benefit was not proven (2012) and not proven for further combinations (2013); linagliptin has no Festbetrag.
US pharmacies paid about $504 for 30 tablets of 5 mg in November 2026 (CMS NADAC); CMS recorded a list price of $488 for 2024. Medicare’s negotiated price from January 1, 2027 is $78 for a 30-day supply (CMS). In Europe, linagliptin 5 mg costs £33.26 for 28 tablets in the UK, €32.67 for 28 in the Netherlands, €47.45 for 30 in Austria (excl. VAT) and CHF 56.45 for 30 in Switzerland — about $39 to $69 for 30 days at ECB rates.
Yes — both are linagliptin 5 mg tablets from Boehringer Ingelheim; the name is spelled Tradjenta in the US and Trajenta in Europe (FDA label, EMA).
The $488 is CMS’s figure for 2024. In November 2026 the national pharmacy acquisition cost was $16.79540 per tablet, or $504 for 30 (NADAC, our calculation) — about 3% above the 2024 figure. Boehringer’s own US price page could not be opened from our location, so we cannot show its current list price.
In England each prescription item costs £9.90; in Switzerland insured patients pay a 10% share after the deductible; in Austria a €7.55 prescription fee for the specified uses; in the Netherlands it is reimbursed under conditions and counts toward the annual deductible. In Medicare, it depends on the Part D plan.
CMS negotiates only drugs without generic competition, and the US pharmacy price survey (NADAC, November 4, 2026) lists only Tradjenta. In the UK, Boehringer now supplies it under the generic name at the same price.
Wellness Vision does not sell medicine, recommend pharmacies or suppliers, or take payments from drug makers. Every price above comes from the official source cited; currency conversions and 30-day figures are our own calculations, shown with their formula. This is a cost comparison, not medical advice.
You shouldn't have to go broke to feel whole.
